LifeArc Ventures
Corporate VCLondon · Seed–Growth · 12 people tracked
Investment thesis
LifeArc Ventures forms part of LifeArc's long-term financial sustainability strategy and pursues two investment strategies: a direct investment fund and a life sciences fund-of-funds programme. The direct venture fund backs early-stage life sciences companies from seed to Series A, reserving significant follow-on capital for successful portfolio companies. As the venture arm of a medical research charity focused on rare diseases and drug-resistant infections, it aims to advance innovation where progress might otherwise stall and help medical breakthroughs reach patients faster.
Source: firm website, verified Aug 7, 2026.
Team · 12 people
from the firm's website
What they invest in
from 12 of 23 portfolio companiesHealthtech ×11Biotech ×10Digital Health ×2Consumer ×1Hardware ×1Medical Devices ×1Mental Health ×1Wellness & Fitness ×1
HQs:United States×3Germany×1
Investments · 23 tracked
founders shown can be your intro pathAffect provides integrated mental health and addiction treatment through a smartphone app, combining therapy, medication management, and behavioral incentives.
Digital HealthHealthtechMental HealthNew York, US
Kevin Ryan(Director)Kristin Muhlner(Executive Officer, Director)Jeff DeFlavio(Director)
BoardJeff Rinehart(Director)
Molecular diagnostics company offering clinical PCR systems using automation and microfluidics; acquired by QIAGEN in September 2020.
BiotechHealthtechAlbuquerque, US
Thomas Duensing(Executive Officer)Dennis Hynson(Executive Officer)Janette Phi(Executive Officer)R. Terry Dunlay(Executive Officer, Director)Sundaresh Brahmasandra(Executive Officer)Edward Michael(Director)
Climb Bio develops monoclonal antibody therapies for immune-mediated diseases, advancing clinical-stage candidates such as budoprutug for conditions including immune thrombocytopenia.
BiotechHealthtech
Cumulus Neuroscience develops the NeuLogiq platform, which combines digital cognitive assessments and neurophysiological (brain function) data for in-clinic and at-home longitudinal monitoring.
BiotechDigital HealthHealthtech
Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers.
BiotechHealthtech
Fluid Biomed develops the ReSolv stent, a hybrid polymer-metal, self-expanding flow-diverting stent designed to treat brain aneurysms and reduce the risk of rupture and stroke.
BiotechHealthtechMedical Devices
Hillstar Bio develops precision immunotherapies for autoimmune diseases, using antibody engineering to selectively deplete pathogenic immune cells while sparing healthy ones.
BiotechHealthtech
Ikarovec is a company focused on age-related macular degeneration (AMD), an eye condition that impairs central vision and can progress from Dry AMD to Wet AMD.
BiotechHealthtech
A UK-based preclinical biotechnology company developing antibody drugs against ion channels and GPCRs using proprietary KnotBody technology.
MC Sciences is a biotech company developing first-in-class mast cell therapeutics based on a discovered mast cell receptor, aimed at diseases across immunology, dermatology, respiratory, gastrointestinal, fibrotic and chronic inflammatory conditions such as chronic urticaria, systemic mastocytosis, COPD, asthma and MCAS.
BiotechHealthtech
Gerhard J. Molderings(Founder)Wolfgang Taumann(CEO & Co-Founder)Mikael Dolsten(Board Chairman)
Ozlo makes Sleepbuds, small in-ear devices that use tuned sound to mask disruptive noises like snoring and traffic, plus environmental sensors that track how noise, light, and temperature affect sleep.
ConsumerHardwareWellness & Fitness
Developing PTD802, a therapeutic candidate for multiple sclerosis (received FDA IND clearance).
RQ Bio discovers and develops long-acting monoclonal antibodies (LAAbs) targeting seasonal influenza to provide protection against severe viral disease.
BiotechHealthtech
Frequently asked questions
- What stage does LifeArc Ventures invest at?
- LifeArc Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does LifeArc Ventures focus on?
- LifeArc Ventures focuses on Biotech, Digital Health, Healthtech, IoT, Medical Devices.
- Where is LifeArc Ventures located?
- LifeArc Ventures is headquartered in London, GB.
- Does LifeArc Ventures lead rounds?
- Yes, LifeArc Ventures leads investment rounds.
Similar investors
Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools and devices, biochemistry-based technologies, digital health applications, and other novel healthcare solutions. It invests across all stages and also builds companies itself.
MDI Ventures is the corporate venture capital arm of Indonesia's Telkom Group, investing in technology startups and emphasizing measurable social and environmental impact alongside financial returns.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
SBCVC (SoftBank China Venture Capital) is a venture capital and private equity fund management firm founded in 2000, focused on investing in high-growth, high-tech companies in Greater China.
BDC Capital's venture capital arm makes fund investments, and is a limited partner in Amplitude Ventures' Fund I. This page profiles Amplitude Ventures, a portfolio fund.